SignatureFD
COGT icon

SignatureFD’s Cogent Biosciences COGT Stock Holding History

SignatureFD’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.99K Buy
187
+86
+85% +$3.18K ﹤0.01% 2883
2026
Q2 		$3.91K Sell
101
-17
-14% -$595 ﹤0.01% 2942
2026
Q1 		$4.54K Buy
118
+17
+17% +$628 ﹤0.01% 2810
2025
Q4 		$3.59K Hold
101
– – ﹤0.01% 2809
2025
Q3 		$1.45K Hold
101
– – ﹤0.01% 3018
2025
Q2 		$725 Sell
101
-110
-52% -$610 ﹤0.01% 3063
2025
Q1 		$1.26K Buy
211
+91
+76% +$713 ﹤0.01% 2992
2024
Q4 		$936 Hold
120
– – ﹤0.01% 3045
2024
Q3 		$1.3K Hold
120
– – ﹤0.01% 2945
2024
Q2 		$1.01K Hold
120
– – ﹤0.01% 2900
2024
Q1 		$806 Buy
120
+44
+58% +$272 ﹤0.01% 2974
2023
Q4 		$447 Buy
+76
New +$582 ﹤0.01% 2987
2023
Q1 		– Sell
-65
Closed -$751 – 3297
2022
Q4 		$751 Sell
65
-15
-19% -$186 ﹤0.01% 3028
2022
Q3 		$1K Buy
+80
New +$1.1K ﹤0.01% 2930

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SignatureFD's COGT Position: Q3 2026 in Review

SignatureFD increased its Cogent Biosciences (COGT) stake by 85% in Q3 2026, buying an estimated $3.18K and bringing the position to 187 shares worth $5.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.

SignatureFD first reported a position in COGT in Q3 2022 and has held it in 14 quarters since. 118 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • SignatureFD held 187 shares of Cogent Biosciences worth $5.99K as of Q3 2026.
  • SignatureFD bought 86 Cogent Biosciences shares in Q3 2026, an estimated $3.18K.
  • Cogent Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2883 holding.
  • SignatureFD first reported a position in Cogent Biosciences in Q3 2022 and has held it in 14 quarters since.
  • 118 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.